Design of Ionizable Lipids To Overcome the Limiting Step of Endosomal Escape: Application in the Intracellular Delivery of mRNA, DNA, and siRNA
Authors:
- 17 March 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 59 (7) , 3046-3062
Abstract
The intracellular delivery of nucleic acid molecules is a complex process involving several distinct steps; among these the endosomal escape appeared to be of particular importance for an efficient protein production (or inhibition) into host cells. In the present study, a new series of ionizable vectors, derived from naturally occurring aminoglycoside tobramycin, was prepared using improved synthetic procedures that allow structural variations on the linker and hydrophobic domain levels. Complexes formed between the new ionizable lipids and mRNA, DNA, or siRNA were characterized by cryo-TEM experiments and their transfection potency was evaluated using different cell types. We demonstrated that lead molecule 30, bearing a biodegradable diester linker, formed small complexes with nucleic acids and provided very high transfection efficiency with all nucleic acids and cell types tested. The obtained results suggested that the improved and “universal” delivery properties of 30 resulted from an optimized endosomal escape, through the lipid-mixing mechanism.Keywords
Funding Information
- Agence Nationale de la Recherche (ANR-10-IBHU-005)
- Nantes Métropole (ANR-10-IBHU-005)
- Region des Pays de la Loire (ANR-10-IBHU-005)
- Bpifrance
This publication has 46 references indexed in Scilit:
- mRNA-based therapeutics — developing a new class of drugsNature Reviews Drug Discovery, 2014
- Gene therapy and DNA delivery systemsInternational Journal of Pharmaceutics, 2014
- A review of the current status of siRNA nanomedicines in the treatment of cancerBiomaterials, 2013
- RNA: The new revolution in nucleic acid vaccinesSeminars in Immunology, 2013
- Introduction to Viral Vectors2011
- Knocking down barriers: advances in siRNA deliveryNature Reviews Drug Discovery, 2009
- Engineering targeted viral vectors for gene therapyNature Reviews Genetics, 2007
- Viral Vectors for Gene TransferDrugs, 2000
- A triploblast origin for Myxozoa?Nature, 1998
- The Basic Science of Gene TherapyScience, 1993